Search

Ipsen SA.

Gesloten

SectorFinanciën

158.4 -2.28

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

157.2

Max

158.9

Belangrijke statistieken

By Trading Economics

Inkomsten

110M

Verkoop

1.9B

K/W

Sectorgemiddelde

30.394

22.624

Dividendrendement

0.87

Winstmarge

5.899

Werknemers

5,535

EBITDA

466M

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+9.22% upside

Dividenden

By Acuity

Dividendrendement

Sectorgemiddelde

0.87%

4.58%

Volgende Winsten

30 jul 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

13B

Vorige openingsprijs

160.68

Vorige sluitingsprijs

158.4

Nieuwssentiment

By Acuity

85%

15%

407 / 438 Rangschikking in Finance

Ipsen SA. Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

25 jul 2026, 00:06 UTC

News
Correlated Moves

Alphabet shares are lower after reports of Waymo's potential split from Uber, impacting the robotaxi market dynamics. Barclays maintains a Buy rating on the stock.

25 jul 2026, 00:02 UTC

News
Social Media

Uber Technologies is shifting its autonomous vehicle strategy by dissolving its exclusivity agreement with Waymo in Atlanta and Austin. Shares are higher in after-market trading.

25 jul 2026, 00:02 UTC

News

Boeing Co's $695 billion backlog supports a decade of revenue visibility. Shares are higher in after-market trading, recovering from earlier session volatility.

25 jul 2026, 00:02 UTC

News

ServiceNow shares declined in after-hours trading following a quarterly revenue report of $4 billion and raised subscription income guidance amid AI-related concerns.

25 jul 2026, 00:02 UTC

News

Elme Communities announced the sale of six properties for $294 million. Shares are trading higher in after-market hours following the update on liquidation activities.

25 jul 2026, 00:02 UTC

News
Correlated Moves

Liberty Energy reported Q2 revenue growth to $1.19 billion, but faced margin compression. Shares were roughly flat in after-market trading following the results.

25 jul 2026, 00:01 UTC

News

Under Armour shares are trading lower in after-market hours amid concerns over declining revenue, rising debt, and cash burn of $162.2 million.

25 jul 2026, 00:01 UTC

News

Carrier Global appointed PTC's Neil Barua to its board, effective immediately. Shares are higher in after-market trading amid positive sentiment about the company's strategy.

25 jul 2026, 00:01 UTC

News

Boston Scientific shares are higher in after-market hours despite a safety alert from the FDA regarding its ENROUTE Transcarotid Neuroprotection System catheters.

25 jul 2026, 00:01 UTC

News

Datadog Inc. is trading higher in after-market hours, buoyed by steady quarter-over-quarter revenue growth despite competition from CoreWeave and broader market turmoil.

24 jul 2026, 23:51 UTC

News

Tenet Healthcare reported second-quarter earnings of $6.12 per share, exceeding estimates. Shares are trading higher in after-market hours following the strong results.

24 jul 2026, 23:46 UTC

News

HF Sinclair Corp has filed a lawsuit against the EPA over biofuel blending delays. Shares rose during after-market hours, maintaining a strong monthly performance.

24 jul 2026, 23:41 UTC

News

Kinsale Capital Group reported Q2 earnings of $5.54 per share, exceeding estimates, with revenue of $548.5 million, driving shares higher in after-market trading.

24 jul 2026, 23:41 UTC

Macro News
ETF Constituents
News

The Vanguard Information Technology ETF is higher in after-market hours, supported by key holdings like Apple and Qualcomm, despite broader market declines.

24 jul 2026, 23:41 UTC

News

Datadog Inc. is higher in after-market trading, benefiting from steady quarter-over-quarter revenue growth despite being surpassed by CoreWeave in total revenue.

24 jul 2026, 23:41 UTC

News

Boeing Co shares advanced in after-market hours, supported by a $695 billion backlog and positive analyst outlook on growth potential.

24 jul 2026, 23:36 UTC

News

KKR & Co Inc shares are lower in after-market hours following a $238.954 million share sale, reflecting potential liquidity concerns and capital allocation shifts.

24 jul 2026, 23:31 UTC

News

Interactive Brokers Group reported a 77% pre-tax profit margin but shares are lower in after-market hours amid concerns over rising interest rates and profitability.

24 jul 2026, 23:21 UTC

News
Social Media

Micron Technology Inc shares are declining in after-market trading amid concerns over potential pricing pressures in the cyclical memory chip market.

24 jul 2026, 23:21 UTC

Social Media
News

Warner Bros Discovery shares are lower in after-market trading as merger plans with Paramount Skydance are postponed until June 2027 amid legal challenges.

24 jul 2026, 23:21 UTC

News

Baker Hughes Co shares rose in after-market hours after a decrease in the active rig count, which fell to 587, the lowest since mid-July.

24 jul 2026, 23:16 UTC

News

CS PowerTech has launched its photovoltaic cell facility in Indiana, boosting Canadian Solar's U.S. manufacturing capabilities. Shares are higher in after-market trading.

24 jul 2026, 23:16 UTC

News

Liberty Energy reported Q2 revenue of $1.19 billion, exceeding estimates. Shares are higher in after-market trading following the earnings release.

24 jul 2026, 23:06 UTC

News

American Airlines Group Inc shares are lower in after-market hours following weaker profit guidance for the third quarter amid rising fuel costs.

24 jul 2026, 23:01 UTC

ETF Constituents
News

Vanguard Growth ETF advances in after-market trading, supported by contributions from Apple, Uber, and Applied Materials, following three lower daily closes.

24 jul 2026, 23:01 UTC

News

Elme Communities announced property sales totaling $294 million and revised liquidating distributions to $16.41 to $16.61 per share, trading higher in after-market hours.

24 jul 2026, 23:01 UTC

News

CACI International Inc. shares declined in after-market trading, influenced by a downturn in the Research & Consulting Services sub-sector.

24 jul 2026, 23:01 UTC

News

Emerson Electric Co shares are lower in after-market trading amid mixed market sentiment influenced by geopolitical tensions and new tariffs from the Trump administration.

24 jul 2026, 23:01 UTC

News

Carrier Global Corp shares declined in after-market hours following the appointment of PTC's Neil Barua to its board, effective immediately.

24 jul 2026, 23:01 UTC

News

Boston Scientific shares are higher in after-market hours despite a safety alert from the FDA regarding its ENROUTE Transcarotid Neuroprotection System catheters.

Peer Vergelijking

Prijswijziging

Ipsen SA. Prognose

Koersdoel

By TipRanks

9.22% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 173 EUR  9.22%

Hoogste 235 EUR

Laagste 117 EUR

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor Ipsen SA. - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

5 ratings

1

Buy

4

Hold

0

Sell

Sentiment

By Acuity

407 / 438 Rangschikking in Financiën

Nieuwssentiment

Zeer Sterk Bearish Bewijs

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Ipsen SA.

Ipsen S.A. operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, and rare diseases. Its product pipeline comprises Cabometyx + Atezolizumab, which is in phase III clinical trial for the treatment of second line metastatic castration-resistant prostate cancer; lenalidomide and rituximab, and Taverik, which is in phase III for the treatment of second line follicular lymphoma; Bylvay, which is in phase III for the treatment of biliary atresia; Dysport, which is in phase III clinical trial for the treatment of chronic and episodic migraine; Fidrisertib, which is in phase II clinical trial for the treatment of fibrodysplasia ossificans progressiva; Elafibranor, which is in phase II for the treatment of primary sclerosing cholangitis, as well as IPN60250; IPN10200, which is in phase II for the treatment of longer-acting neurotoxin aesthetics and therapeutics; IPN60210, which is in phase I clinical trial for the treatment of relapsed/refractory multiple myeloma; and IPN60260 for the treatment of Viral cholestatic disease and is in phase I clinical trial. The company also offers Somatuline, Decapeptyl, Cabometyx, Onivyde, Tazverik, and other oncology products; Dysport and other neurosciences products; and Bylvay, NutropinAq, Increlex, and Sohonos for rare diseases. The company was founded in 1929 and is based in Boulogne-Billancourt, France.
help-icon Live chat